Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Commun ; 7: 12015, 2016 06 28.
Article in English | MEDLINE | ID: mdl-27352007

ABSTRACT

The gut microbiome plays an important role in immune function and has been implicated in several autoimmune disorders. Here we use 16S rRNA sequencing to investigate the gut microbiome in subjects with multiple sclerosis (MS, n=60) and healthy controls (n=43). Microbiome alterations in MS include increases in Methanobrevibacter and Akkermansia and decreases in Butyricimonas, and correlate with variations in the expression of genes involved in dendritic cell maturation, interferon signalling and NF-kB signalling pathways in circulating T cells and monocytes. Patients on disease-modifying treatment show increased abundances of Prevotella and Sutterella, and decreased Sarcina, compared with untreated patients. MS patients of a second cohort show elevated breath methane compared with controls, consistent with our observation of increased gut Methanobrevibacter in MS in the first cohort. Further study is required to assess whether the observed alterations in the gut microbiome play a role in, or are a consequence of, MS pathogenesis.


Subject(s)
Gastrointestinal Microbiome , Multiple Sclerosis, Relapsing-Remitting/microbiology , RNA, Ribosomal, 16S/genetics , Adult , Breath Tests , Case-Control Studies , Female , Genes, Bacterial , Humans , Immunomodulation , Male , Methane/analysis , Middle Aged , Monocytes/metabolism , Multiple Sclerosis, Relapsing-Remitting/immunology , Multiple Sclerosis, Relapsing-Remitting/therapy , Phylogeny , T-Lymphocytes/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...